Pharmaceuticals News and Research

RSS

Alzheimer disease and the blood brain barrier

Increased production of the amyloid-beta (Abeta) peptide can lead to Abeta aggregation and buildup in the brain and rare familial forms of early onset Alzheimer disease (AD).

20 Oct 2005

EU influenza pandemic preparedness

EU preparedness against an influenza pandemic has improved over the last six months, but Member States need to step up their efforts to strengthen their pandemic preparedness, according to Markos Kyprianou, European Commissioner for Health and Consumer Protection.

19 Oct 2005

A DNA-based vaccine could be a potent weapon against bird flu

Researchers scrambling to combat a virulent form of bird flu that could mutate into a form easily spread among humans should consider developing vaccines based on DNA, according to British biochemical engineers.

19 Oct 2005

As Europe panics, global co-operation urged in the fight against birdflu

As the panic about bird flu spreads across Europe, EU foreign ministers are urging global cooperation in efforts to tackle the threat of the deadly virus.

19 Oct 2005

Bayer to produce new Tuberculosis drug at low prices for poor nations

A promising new antibiotic, moxifloxacin, produced by Bayer Healthcare is about to be tested against tuberculosis, a disease that kills 5,000 people a day.

18 Oct 2005

Isotretinoin-related birth defects

Isotretinoin (also known as Accutane) is a drug used to treat severe acne, but it can cause birth defects when taken by pregnant women. Because of these risks, the U.S. Food and Drug Administration and Roche Pharmaceuticals (Accutane's manufacturer) developed a voluntary pregnancy prevention program (PPP) in 1988 to try and prevent conception in women taking the drug.

16 Oct 2005

Fijiian seaweed shows potential to kill cancer cells, bacteria and the HIV virus

Researchers have discovered 10 new molecular structures with pharmaceutical potential in a species of red seaweed that lives in the shallow coral reef along the coastline of Fiji in the south Pacific Ocean.

12 Oct 2005

Quest to develop synthetic versions of rare natural substances to cure tobacco-related diseases

Within a laboratory on the Florida State University campus, a chemist leads a team of researchers in a quest to develop synthetic versions of rare natural substances. If all goes well, the team’s efforts could pay off in the form of the next generation of cancer-fighting drugs.

12 Oct 2005

Arena Pharmaceuticals issue new patent

Arena Pharmaceuticals has announced that it was issued US patent number 6,953,787, entitled "5-HT2C Receptor Modulators," by the United States Patent and Trademark Office.

11 Oct 2005

Myriad Genetics nears completion of antithrombin drug trial

Myriad Genetics announced today that it is rapidly nearing completion of the preclinical data package on MPC-0920, its antithrombin drug candidate, for submission to the FDA prior to beginning human clinical trials.

11 Oct 2005

100% efficacy for cervical cancer vaccine

Final-stage clinical trials of a cervical cancer vaccine developed by University of Queensland (UQ) scientists, have shown the drug to be 100 per cent effective.

10 Oct 2005

Specific gene on chromosome 15 regulates inflammation

A team of international researchers has discovered that a specific gene on chromosome 15 regulates inflammation, a finding with implications for a wide range of disorders, including cancer, cardiovascular disease, diabetes, obesity, Alzheimer's, and infections. The findings are published in the October 9 online issue of Nature Genetics.

9 Oct 2005

Avian influenza and the U.S

If a virulent strain of avian influenza ever struck the U.S. poultry industry, this country probably would fare better than many other nations due to careful biosecurity procedures in force.

9 Oct 2005

Ischemic brain injury - another promising avenue for stem cell therapy

Adult stem cell therapy quickly and significantly improves recovery of motor function in an animal model for the ischemic brain injury that occurs in about 10 percent of babies with cerebral palsy, researchers report.

4 Oct 2005

Concerta, a once-daily form of the drug methylphenidate, successfully controlled ADHD symptoms

A new study has found that an all-day, extended-release stimulant for treating attention-deficit hyperactivity disorder (ADHD) remains effective for up to two years without significant side effects.

3 Oct 2005

Chicken virus helps develop novel vaccines

Researchers at the University of South Australia are developing novel vaccines by using a chicken virus to either stimulate or suppress the body's immune system.

28 Sep 2005

Substance found in cotton plant could help treat psoriasis

A substance found in the cotton plant could help treat the common skin disease psoriasis, according to new research from the Pharmacy School at Sunderland University launched at the British Pharmaceutical Conference in Manchester.

28 Sep 2005

Drug-releasing intravaginal ring could help prevent women from contracting HIV infection

The silicone vaginal ring steadily releases aciclovir: a treatment for genital herpes. It is known that women with genital herpes are at increased risk of HIV infection because the genital blisters caused by the infection increase the transmissibility of sexually acquired HIV.

28 Sep 2005

100 year old technology to fight MRSA

A technique that has been around for more than one hundred years is being used in new research as a way of killing methicillin-resistant Staphylococcus aureus (MRSA) using light. The research to be reported today at the British Pharmaceutical Conference in Manchester, is being undertaken by researchers from Queen's University Belfast.

28 Sep 2005

Pain-free needles!

Millions of fearful patients could be saved the pain of vaccinations thanks to revolutionary pain-free needles to be revealed today for the first time at the British Pharmaceutical Conference in Manchester.

28 Sep 2005